Table 4

Median change in bone microarchitectural parameters between baseline and time point C at distal tibia in a subgroup of patients with long-term follow-up and comparison with a control group.

TibiaBaselineTime CMedian % increase between baseline and time C, pControl groupMeans differencep*
Tb.vBMD, mgHA/cm388.8 ± 57.688.0 ± 49.8+2.0, .021174.7 ± 50.5−49.6<.001
Ct.vBMD, mgHA/cm3788.0 ± 120.3840.1 ± 83.0+3.4, .049881.6 ± 54.2−4.7.110
Tb.N, 1/mm1.12 ± 0.481.08 ± 0.56−0.2, .5861.98 ± 0.42−45.4<.001
Tb.Th, mm0.060 ± 0.0430.066 ± 0.032−6.7, .5240.074 ± 0.017−10.8.209
Tb.Sp, mm1.072 ± 0.7001.195 ± 0.791+1.2, .2610.454 ± 0.125+163.2<.001
Tb.BV/TV, %6.5 ± 5.36.7 ± 5.0−9.9, .75214.5 ± 4.2−53.8<.001
Ct.Th, mm0.71 ± 0.340.89 ± 0.26+13.8, .0401.22 ± 0.32−27.0.009
TibiaBaselineTime CMedian % increase between baseline and time C, pControl groupMeans differencep*
Tb.vBMD, mgHA/cm388.8 ± 57.688.0 ± 49.8+2.0, .021174.7 ± 50.5−49.6<.001
Ct.vBMD, mgHA/cm3788.0 ± 120.3840.1 ± 83.0+3.4, .049881.6 ± 54.2−4.7.110
Tb.N, 1/mm1.12 ± 0.481.08 ± 0.56−0.2, .5861.98 ± 0.42−45.4<.001
Tb.Th, mm0.060 ± 0.0430.066 ± 0.032−6.7, .5240.074 ± 0.017−10.8.209
Tb.Sp, mm1.072 ± 0.7001.195 ± 0.791+1.2, .2610.454 ± 0.125+163.2<.001
Tb.BV/TV, %6.5 ± 5.36.7 ± 5.0−9.9, .75214.5 ± 4.2−53.8<.001
Ct.Th, mm0.71 ± 0.340.89 ± 0.26+13.8, .0401.22 ± 0.32−27.0.009

Abbreviations: Tb.vBMD, trabecular density; Ct.vBMD, cortical density; Tb.N, trabecular number; Tb.Th, trabecular thickness; Tb.Sp, trabecular separation; Ct.Th, cortical thickness; Tb.BVTV, trabecular bone volume fraction.

*Comparison between time point C in patients with TIO (subgroup analysis of 10 patients with long-term follow-up) and control group.

Table 4

Median change in bone microarchitectural parameters between baseline and time point C at distal tibia in a subgroup of patients with long-term follow-up and comparison with a control group.

TibiaBaselineTime CMedian % increase between baseline and time C, pControl groupMeans differencep*
Tb.vBMD, mgHA/cm388.8 ± 57.688.0 ± 49.8+2.0, .021174.7 ± 50.5−49.6<.001
Ct.vBMD, mgHA/cm3788.0 ± 120.3840.1 ± 83.0+3.4, .049881.6 ± 54.2−4.7.110
Tb.N, 1/mm1.12 ± 0.481.08 ± 0.56−0.2, .5861.98 ± 0.42−45.4<.001
Tb.Th, mm0.060 ± 0.0430.066 ± 0.032−6.7, .5240.074 ± 0.017−10.8.209
Tb.Sp, mm1.072 ± 0.7001.195 ± 0.791+1.2, .2610.454 ± 0.125+163.2<.001
Tb.BV/TV, %6.5 ± 5.36.7 ± 5.0−9.9, .75214.5 ± 4.2−53.8<.001
Ct.Th, mm0.71 ± 0.340.89 ± 0.26+13.8, .0401.22 ± 0.32−27.0.009
TibiaBaselineTime CMedian % increase between baseline and time C, pControl groupMeans differencep*
Tb.vBMD, mgHA/cm388.8 ± 57.688.0 ± 49.8+2.0, .021174.7 ± 50.5−49.6<.001
Ct.vBMD, mgHA/cm3788.0 ± 120.3840.1 ± 83.0+3.4, .049881.6 ± 54.2−4.7.110
Tb.N, 1/mm1.12 ± 0.481.08 ± 0.56−0.2, .5861.98 ± 0.42−45.4<.001
Tb.Th, mm0.060 ± 0.0430.066 ± 0.032−6.7, .5240.074 ± 0.017−10.8.209
Tb.Sp, mm1.072 ± 0.7001.195 ± 0.791+1.2, .2610.454 ± 0.125+163.2<.001
Tb.BV/TV, %6.5 ± 5.36.7 ± 5.0−9.9, .75214.5 ± 4.2−53.8<.001
Ct.Th, mm0.71 ± 0.340.89 ± 0.26+13.8, .0401.22 ± 0.32−27.0.009

Abbreviations: Tb.vBMD, trabecular density; Ct.vBMD, cortical density; Tb.N, trabecular number; Tb.Th, trabecular thickness; Tb.Sp, trabecular separation; Ct.Th, cortical thickness; Tb.BVTV, trabecular bone volume fraction.

*Comparison between time point C in patients with TIO (subgroup analysis of 10 patients with long-term follow-up) and control group.

Close
This Feature Is Available To Subscribers Only

Sign In or Create an Account

Close

This PDF is available to Subscribers Only

View Article Abstract & Purchase Options

For full access to this pdf, sign in to an existing account, or purchase an annual subscription.

Close